Resverlogix Corp. announced two additional results from the ongoing analysis of its Phase 2b ASSURE clinical trial using intravascular ultrasound (IVUS) to study high-risk cardiovascular disease (CVD) patients for assessing benefits of RVX-208.

study conducted in Ireland found that aspirin does not adequately protect 20 percent of patients with established heart disease.

Many healthcare systems are finding their general PACS and cardiology PACS are both aging and their image storage is reaching capacity. How do the diagnostic imaging departments address the needs of their cardiologists and radiologists?


The tiny device, about the size of the head of a pen, can be delivered via a delivery catheter through the venous system and placed directly into the myocardium of the right ventricle. 


Neovasc Inc. announced that the first patent covering the company's innovative Tiara transcatheter mitral valve replacement technology has been issued by the U.S. Patent and Trademark Office. The new patent protects key aspects of the Tiara mitral valve prosthesis. 

The RSNA FastPass is produced by Imaging Technology News (ITN) as a guide to what vendors are highlighting. It helps attendees better navigate the vast technical exhibit floor to find what they are looking for.


As health IT leaders make their way to New York for the New York eHealth Collaborative (NYeC) Digital Health Conference, Practice Fusion, the nation's largest healthcare platform, is looking at the key healthcare trend from 2013 and predicts what they might mean looking forward.


Subscribe Now